Advanced Ovarian Cancer and Carboplatin
Links shared publicly online about this topic
Oncology Article | Carboplatin Ovarian Neoplasms
mdlinx.com — “Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients” View full resource at mdlinx.com
Most Recently Shared on June 2, 2011 at 6:04 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian ... http://bit.ly/jccmI8 #oncology
Oncology Article | Carboplatin Ovarian Neoplasms
mdlinx.com — “Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The Mito-2 Randomized Phase III Trial” View full resource at mdlinx.com
Most Recently Shared on August 18, 2011 at 6:19 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line trea... http://t.co/gQvyhct #oncology
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard o” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 3:37 pm By:
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin De.. http://dld.bz/AcP7
Oncology Article | Camptothecin Ovarian Neoplasms Carboplatin
mdlinx.com — “Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on December 7, 2010 at 9:14 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatmen... http://bit.ly/dJ8a4s #oncology
Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel
mdlinx.com — “Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on January 31, 2011 at 6:17 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-r... http://bit.ly/eDTbxA #oncology
Medical News: SGO: Hunt for Ovarian Regimen Focuses on Carboplatin - in Meeting Coverage, SGO from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Intraperitoneal (IP) carboplatin might offer a better-tolerated alternative to intraperitoneal cisplatin for treatment of advanced ovarian cancer, results of a preliminary clinical st” View full resource at medpagetoday.com
Most Recently Shared on March 22, 2010 at 12:18 am By:
SGO: Hunt for Ovarian Regimen Focuses on Carboplatin (CME/CE) http://bit.ly/aOfbyg
Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel
mdlinx.com — “Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/ refractory epithelial ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on July 13, 2011 at 7:49 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery o... http://bit.ly/qLdG64 #oncology
PLD/carboplatin to replace paclitaxel/carboplatin as gold-standard treatment for platinum-sensitive ovarian cancer
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.” View full resource at news-medical.net
Most Recently Shared on December 10, 2010 at 3:43 pm By:
Ovarian Cancer News: PLD/carboplatin to replace paclitaxel/carboplatin as gold-standard treatment for platinum-s... http://bit.ly/gI3hGR
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Disabled World Health Advocate and Health News
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial : The Lancet
thelancet.com — “Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. By - Prof Elisabe...” View full resource at thelancet.com
Most Recently Shared on August 9, 2011 at 2:37 pm By:
Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study http://t.co/GGUhJbj
For the Treatment of Second-Line Platinum Sensitive Advanced Ovarian Cancer, One-Third of Surveyed Oncologists Indicate That Paclitaxel/Carboplatin Has the Best Overall Clinical Profile When Compared to Other Currently Available Therapies | Business Wire
businesswire.com — “Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatme” View full resource at businesswire.com
Most Recently Shared on January 27, 2011 at 8:25 pm By:
For the Treatment of Second-Line Platinum Sensitive Advanced Ovarian Cancer, One-Third of Surveyed Oncologists .... http://bit.ly/gehjWc
Adding Bevacizumab to Carboplatin/Gemcitabine Extends Progression-Free Survival in Recurrent Ovarian Cancer - MPR
empr.com — “Bevacizumab + carboplatin/gemcitabine followed by bevacizumab until disease progression provided a clinically meaningful benefit in women with platinum-sensitive recurrent ovarian cancer, representing the first Phase 3 trial of an antiangiogenic agent to demonstrate such a benefit, investigators reported during the American Society of Clinical Oncology's 2011 Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 5, 2011 at 6:53 pm By:
#asco2011 Adding Bevacizumab to Carboplatin/Gemcitabine Extends Progression-Free Survival in… http://goo.gl/fb/MUWQq
Ovarian cancer advances when genes are silenced
eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at eurekalert.org
Most Recently Shared on December 14, 2010 at 4:41 pm By:
Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer " JCO
jco.ascopubs.org — “Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer " JCO” View full resource at jco.ascopubs.org
Most Recently Shared on September 17, 2010 at 11:38 am By:
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial O... http://bit.ly/b728h5
Ovarian cancer advances when genes are silenced
labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.” View full resource at labspaces.net
Most Recently Shared on December 14, 2010 at 4:48 pm By:
Ovarian cancer advances when genes are silenced - http://is.gd/iJVou
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
medical_tweets
Advertisement
